Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Oberweis Emerging Growth Fund (OBEGX)

Net Asset Value
1 Day
Overall Morningstar Rating
Small growth
Style or Category
No Load
Sales Expenses
Expense Ratio
Morningstar Risk Rating™
Investment Objective The investment seeks to maximize capital appreciation. The fund invests, under normal circumstances, at least 80% of its net assets in the securities of relatively small companies, which, at the time of investment, have a market capitalization of less than or equal to $1.5 billion or are within the range of companies represented in the MSCI ACWI Small-Cap Index, whichever is greater and meet the Oberweis Aperture investment criteria. It may invest without limit in U.S. and non-U.S. companies. The fund may invest in equity-linked certificates issued and/or guaranteed by counterparties rated A or better by Moody's or S&P Corporation.


1 month+1.12% 3 years+20.41%
3 months+4.94% 5 years+14.33%
1 year+21.75% Since inception+9.10%
Data through --

Peer Comparisonvs. Small growth

Performance 5-yr return+14.33%+17.65%
Expense ratio1.49%1.37%
Risk 5 year sharpe ratio0.811.05
Net assets$57.3M$835.3M
Average market cap$1.6B$2.9B
Average P/E30.228.2
Portfolio turnover95%95%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyOberweis
Fund manager & tenureJames Oberweis / 13 Years
Minimal initial investment$1,000.00
Minimum IRA investment$500.00


U.S. stock56.30%
International stock44.09%
Fixed income0.00%
Top 5 Sectors
Portfolio weighting
Hardware 28.86%
Industrial materials 12.12%
Business service 10.75%
Healthcare 10.70%
Consumer service 9.01%
Top 10 Holdings
Portfolio weighting
SYNA Synaptics Inc4.13%
VIPS Vipshop Holdings Ltd3.54%
ININ Interactive Intelligence Group Inc3.35%
FNGN Financial Engines Inc3.34%
MEI Methode Electronics Inc3.18%
MMS Maximus Inc2.90%
SNCR Synchronoss Technologies Inc2.86%
LGND Ligand Pharmaceuticals Inc2.85%
EGHT 8x8 Inc2.77%
ATRO Astronics Corp2.71%